NYSE:ALB - Albemarle Stock Price, News, & Analysis

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle announced a quarterly dividend on Wednesday, May 8th. Stockholders of record on Friday, June 14th will be paid a dividend of $0.3675 per share on Monday, July 1st. This represents a $1.47 dividend on an annualized basis and a dividend yield of 2.17%. The ex-dividend date of this dividend is Thursday, June 13th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) posted its quarterly earnings data on Wednesday, May, 8th. The specialty chemicals company reported $1.23 EPS for the quarter, beating the Zacks' consensus estimate of $1.21 by $0.02. The specialty chemicals company earned $832.06 million during the quarter, compared to analysts' expectations of $827.94 million. Albemarle had a return on equity of 15.53% and a net margin of 20.54%. The company's revenue for the quarter was up 1.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.30 EPS. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Albemarle.

Albemarle updated its FY19 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of $6.10 to $6.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.20. The company issued revenue guidance of $3.65 billion to $3.85 billion, compared to the consensus revenue estimate of $3.68 billion.Albemarle also updated its FY 2019 guidance to $6.10-6.50 EPS.

15 brokers have issued 1 year target prices for Albemarle's stock. Their predictions range from $59.00 to $125.00. On average, they expect Albemarle's share price to reach $95.7740 in the next year. This suggests a possible upside of 41.4% from the stock's current price. View Analyst Price Targets for Albemarle.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle.

Media headlines about ALB stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Albemarle earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave news stories about the specialty chemicals company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Hexcel (HXL), Sinopec Shanghai Petrochemical (SHI), Rogers (ROG), PolyOne (POL), Trinseo (TSE), Kraton (KRA), AdvanSix (ASIX), A Schulman (SHLM), Cereplast (CERPQ) and ForceField Energy (FNRG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Valeant Pharmaceuticals Intl (VRX).

Albemarle's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.20%), Primecap Management Co. CA (4.17%), Baillie Gifford & Co. (2.49%), Principal Financial Group Inc. (1.62%), Dimensional Fund Advisors LP (1.41%) and Artisan Partners Limited Partnership (1.39%). Company insiders that own Albemarle stock include Deeanne J Marlow, Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Iridian Asset Management LLC CT, Federated Investors Inc. PA, CIBC Private Wealth Group LLC, Marshall Wace LLP, Wells Fargo & Company MN, SEI Investments Co and SG Americas Securities LLC. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Scott Tozier. View Insider Buying and Selling for Albemarle.

ALB stock was bought by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Dimensional Fund Advisors LP, Primecap Management Co. CA, Artisan Partners Limited Partnership, BlackRock Inc., Oxford Asset Management LLP, US Bancorp DE and Janney Capital Management LLC. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $67.72.

Albemarle has a market capitalization of $7.18 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $693.56 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,900 workers across the globe.

The official website for Albemarle is http://www.albemarle.com.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]